C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/1986
03/25/1986	US4578219 Contraceptive vaccine
03/25/1986	CA1202303A2 Antagonists of the vasopressor action of argonine vasopressin
03/25/1986	CA1202261A1 A47934 antibiotic and its production
03/13/1986	WO1986001408A1 Antiviral peptides
03/12/1986	EP0173937A2 Method of increasing the permeability of yeast cells
03/11/1986	CA1201710A1 Analgesic compounds
03/05/1986	EP0173557A2 Peptides
03/05/1986	EP0173481A2 Peptides
03/05/1986	EP0173384A2 Polypeptide relating to alpha-hANP
02/1986
02/27/1986	WO1986001211A1 Immunotherapeutic polypeptide agents
02/27/1986	WO1986001210A1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
02/27/1986	WO1986001209A2 NEW p-PHENYLENEDIAMINE PEPTIDES AND REACTANCE CONTAINING THEM FOR THE DETERMINATION OF PROTEASES OF THE BLOOD COAGULATION SYSTEM
02/19/1986	EP0171477A2 Amino acid-containing therapeutic compounds
02/18/1986	CA1200777A1 A-21978c cyclic peptide derivatives and their production
02/13/1986	WO1986000991A1 Method for determining mimotopes
02/13/1986	WO1986000911A1 Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
02/12/1986	EP0171315A1 Process for the synthesis of hGRF (Somatocrinin) in the liquid phase, and intermediary peptides
02/12/1986	EP0171276A2 Process for inhibiting peptide carbamylation
02/12/1986	EP0171270A2 Process for the preparation of angiotensin-II analogues substituted in the 1-, 5- and 8-positions
02/12/1986	EP0171260A2 Hepatitis B vaccine
02/11/1986	US4569927 GnRH Antagonists IV
02/11/1986	US4569907 Thiopeptolide substrates for vertebrate collagenase
02/11/1986	CA1200547A2 Antagonists of the antidiuretic action of arginine vasopressin
02/05/1986	EP0170550A1 Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them
02/05/1986	EP0170496A2 Vaccine against urinary tract infection
01/1986
01/30/1986	WO1986000622A1 Hexapeptide
01/30/1986	WO1986000621A1 Hexapeptide
01/29/1986	EP0169505A2 Process for preparing oligopeptide
01/28/1986	US4567162 Biologically active heptapeptides
01/22/1986	EP0168401A1 Immunogenic compositions
01/22/1986	EP0088752B1 Antigenic peptide compound
01/21/1986	US4565805 Pharmaceutical preparation for the treatment of peptic ulcer
01/21/1986	US4565804 GnRH Antagonists VI
01/15/1986	EP0167575A1 Cardiodilatine, a new peptide hormone and production process thereof.
01/08/1986	EP0167420A1 Expression vectors for factor IX, cells transformed with these vectors and process for the preparation of factor IX
01/07/1986	US4563305 Radiolabelled substrates for assaying mammalian enzymes
01/03/1986	WO1986000076A1 Process for preparing antibiotic l 17392 (deglucoteicoplanin)
01/03/1986	WO1986000075A1 Carboxylic acid ester derivatives of deglucoteicoplanin
01/02/1986	EP0166612A2 Potent thymopentin analogs
01/02/1986	EP0166548A2 Broad spectrum vaccine against gonorrhea
01/02/1986	EP0166410A2 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
12/1985
12/31/1985	CA1198695A1 Antibiotic compound
12/27/1985	EP0165492A2 Process for manufacturing preparations promoting wound healing, and such preparations
12/24/1985	US4560505 Hypotensive agents
12/18/1985	EP0165151A1 Peptide derivatives as renin inhibitors, process for their preparation and their therapeutical application
12/18/1985	EP0165033A2 Conformationally restricted thymopentin-like compounds
12/18/1985	EP0164654A2 Process for the preparation of peptapeptides acting on the immune system, and their intermediary products
12/17/1985	US4559324 Analgesics
12/17/1985	US4559323 Animal growth regulators; feeds
12/17/1985	CA1198052A1 Region-specific determinants for vitamin k dependent bone protein
12/10/1985	US4558006 Immunoreactive with polypeptide sequence extant of erythropoietin; detecting red blood cell growth stimulating hormone
12/04/1985	EP0163573A1 Site-specific proteolysis by renin
12/04/1985	EP0163237A2 Di- and tri-peptidal renin inhibitors
11/1985
11/27/1985	EP0162575A2 GnRH Antagonists VII
11/27/1985	EP0162422A2 The novel physiologically active substance foroxymithine, a process and microorganisms for its production and its use as medicament
11/27/1985	EP0162414A2 Amphipathic peptides and pharmaceutical compositions containing same
11/27/1985	EP0162079A1 Use of arg-phe-amide derivatives
11/26/1985	US4555403 Pharmacologically active peptides and medicaments containing the same
11/26/1985	CA1197235A1 Enkephalin analogues
11/21/1985	WO1985005125A1 Vectors for the expression of factor ix, cells transformed by said vectors and process for the preparation of factor ix
11/21/1985	WO1985005122A1 Rotavirus
11/21/1985	EP0161468A2 Process for the solid phase synthesis of peptides which contain sulfated tyrosine
11/19/1985	US4554351 Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
11/13/1985	EP0161017A1 Peptides
11/13/1985	EP0161007A2 Retro - inverso C-Terminal hexapeptide analogues of substance P
11/12/1985	US4552864 Gonadoliberin derivatives process for the preparation and pharmaceutical compositions thereof
11/12/1985	US4552701 Vancomycins
11/07/1985	WO1985004883A1 Gif-2 and its preparation
11/07/1985	WO1985004871A1 Leukemia-associated virus immunogen, vaccine and assay
11/07/1985	WO1985004870A1 Novel atrial natriuretic/vasodilator polypeptides
11/05/1985	US4551445 Derivatives of arginine vasopressin antagonists
11/05/1985	US4551273 Analgesic peptide and process for the preparation thereof
10/1985
10/30/1985	EP0159863A2 Improvements in and relating to novel glycopeptide antibiotics
10/24/1985	WO1985004672A1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them
10/24/1985	WO1985004654A1 A peptide vaccine or diagnostic, and a polypeptide useful therefor
10/24/1985	WO1985004653A1 Antibodies to human interleukin-2 induced by synthetic polypeptides
10/24/1985	WO1985004585A1 Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelet with vessel walls
10/24/1985	WO1985004584A1 Method of inhibiting and inducing human platelet aggregation
10/15/1985	US4547489 Oligopeptide having immunoregulatory activity
10/15/1985	US4547370 GnRH Antagonists
10/10/1985	WO1985004397A1 Platelet related growth regulator
10/09/1985	EP0157643A2 Antibodies to human interleukin-2 induced by synthetic polypeptides
10/09/1985	EP0157409A2 Renin inhibitors containing 2-substituted statine
10/09/1985	EP0157235A1 Process for the preparation of proteins
10/08/1985	US4546079 Iron containing or iron-free cultures
10/08/1985	US4545931 Synthetic heat-stable enterotoxin polypeptide of Escherichia coli
10/02/1985	EP0156322A2 Renin inhibitors containing peptide isosteres
10/02/1985	EP0156321A2 Renin inhibitory peptides having improved solubility
10/02/1985	EP0156320A2 Renin inhibitors containing homophe 8 and a C-terminal amide cycle
10/02/1985	EP0156319A2 Renin inhibitors containing homophe 8
10/02/1985	EP0156318A2 C-terminal amide cyclic renin inhibitors containing peptide isosteres
10/02/1985	EP0156280A2 Process for the preparation of peptide intermediates poor in racemates, belonging to gonadorelin and gonadorelin analogues, their synthesis and intermediates obtained by this process
09/1985
09/26/1985	WO1985004103A1 Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
09/24/1985	US4543349 Basic heptapeptide vasopressin antagonists
09/18/1985	EP0155199A1 Hexapeptide, process for its preparation and pharmaceutical compositions thereof
09/18/1985	EP0155147A2 The antigenic determinants of HBxAg
09/18/1985	EP0155146A2 Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
09/18/1985	EP0154902A2 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
09/17/1985	US4542124 Octapeptide vasopressin antagonists
09/12/1985	WO1985003950A1 A sv40 expression vector containing hbxag as an expression marker

1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423